Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling
View abstract on PubMed
Summary
This summary is machine-generated.Hybrid closed-loop systems significantly improve glucose control in type 1 diabetes, reducing glycated hemoglobin and increasing time in range. These advanced systems offer better outcomes than traditional insulin management methods.
Area Of Science
- * Endocrinology and Diabetes Management
- * Medical Technology and Health Informatics
Background
- * Hybrid closed-loop systems represent a novel technological approach for managing type 1 diabetes mellitus (T1DM).
- * These systems integrate continuous glucose monitoring (CGM) with automated insulin delivery via an insulin pump, guided by a control algorithm.
- * Emerging evidence suggests significant potential for these technologies to enhance the quality of life for individuals with T1DM and their families.
Conclusions
- * Hybrid closed-loop systems demonstrate statistically significant improvements in HbA1c, time in range, and hyperglycemic control compared to CSII + CGM.
- * The technology offers enhanced glucose management for individuals with T1DM facing challenges with conventional therapies.
- * While associated with higher costs, the clinical benefits suggest a favorable long-term health economic profile.
Related Concept Videos
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
Blood-sugar Levels
For example, an increase in blood glucose levels releases the hormone insulin from beta cells of the pancreas into the bloodstream, delivering insulin to cells throughout the...

